Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 141 entries
Sorted by: Best Match Show Resources per page
Autocrine transforming growth factor-alpha is associated with modulation of a 130 kD RB protein species and 116/110 Rb as revealed by an antisense TGF alpha expression vector.

International journal of oncology

Dobre C, Ziober B, Humphrey L, Brattain M.
PMID: 21544460
Int J Oncol. 1996 Jun;8(6):1025-33. doi: 10.3892/ijo.8.6.1025.

Specific RE protein species modulated by autocrine TGF alpha are unknown. HCT116 cells transfected with TGF alpha antisense expression vector were compared with control HCT116 NEO for mitogenesis and modulation of high MW (130, 120 kD) and low MW...

Cite
Dobre C, Ziober B, Humphrey L, et al. Autocrine transforming growth factor-alpha is associated with modulation of a 130 kD RB protein species and 116/110 Rb as revealed by an antisense TGF alpha expression vector. Int J Oncol. 1996;8(6):1025-33doi: 10.3892/ijo.8.6.1025.
Dobre, C., Ziober, B., Humphrey, L., & Brattain, M. (1996). Autocrine transforming growth factor-alpha is associated with modulation of a 130 kD RB protein species and 116/110 Rb as revealed by an antisense TGF alpha expression vector. International journal of oncology, 8(6), 1025-33. https://doi.org/10.3892/ijo.8.6.1025
Dobre, C, et al. "Autocrine transforming growth factor-alpha is associated with modulation of a 130 kD RB protein species and 116/110 Rb as revealed by an antisense TGF alpha expression vector." International journal of oncology vol. 8,6 (1996): 1025-33. doi: https://doi.org/10.3892/ijo.8.6.1025
Dobre C, Ziober B, Humphrey L, Brattain M. Autocrine transforming growth factor-alpha is associated with modulation of a 130 kD RB protein species and 116/110 Rb as revealed by an antisense TGF alpha expression vector. Int J Oncol. 1996 Jun;8(6):1025-33. doi: 10.3892/ijo.8.6.1025. PMID: 21544460.
Copy Download .nbib Format: NLM
Superior mesenteric vein thrombosis secondary to oral contraceptive use.

Case reports in vascular medicine

Stewart H, Flannery MT, Humphrey DA.
PMID: 23056989
Case Rep Vasc Med. 2012;2012:969130. doi: 10.1155/2012/969130. Epub 2012 Sep 29.

Superior mesenteric vein thrombosis (SMVT) is a rare yet frequently fatal cause of intestinal ischemia. Despite its severe consequences, SMVT often presents with nonspecific symptoms such as nausea, vomiting, and abdominal pain. It can occur with or without gastrointestinal...

Cite
Stewart H, Flannery MT, Humphrey DA. Superior mesenteric vein thrombosis secondary to oral contraceptive use. Case Rep Vasc Med. 2012;2012:969130doi: 10.1155/2012/969130.
Stewart, H., Flannery, M. T., & Humphrey, D. A. (2012). Superior mesenteric vein thrombosis secondary to oral contraceptive use. Case reports in vascular medicine, 2012969130. https://doi.org/10.1155/2012/969130
Stewart, Heather, et al. "Superior mesenteric vein thrombosis secondary to oral contraceptive use." Case reports in vascular medicine vol. 2012 (2012): 969130. doi: https://doi.org/10.1155/2012/969130
Stewart H, Flannery MT, Humphrey DA. Superior mesenteric vein thrombosis secondary to oral contraceptive use. Case Rep Vasc Med. 2012;2012:969130. doi: 10.1155/2012/969130. Epub 2012 Sep 29. PMID: 23056989; PMCID: PMC3465920.
Copy Download .nbib Format: NLM
Validation of a treatment satisfaction questionnaire in non-Hodgkin lymphoma: assessing the change from intravenous to subcutaneous administration of rituximab.

Patient preference and adherence

Theodore-Oklota C, Humphrey L, Wiesner C, Schnetzler G, Hudgens S, Campbell A.
PMID: 27695295
Patient Prefer Adherence. 2016 Sep 13;10:1767-1776. doi: 10.2147/PPA.S108489. eCollection 2016.

BACKGROUND: A subcutaneous (SC) formulation of rituximab (MabTheraMETHODS: Face and content validity of RASQ-SC and RASQ-IV were qualitatively assessed using 60-minute combined concept elicitation and cognitive debriefing interviews. Psychometric validation of RASQ (item performance and reliability) was assessed quantitatively...

Cite
Theodore-Oklota C, Humphrey L, Wiesner C, et al. Validation of a treatment satisfaction questionnaire in non-Hodgkin lymphoma: assessing the change from intravenous to subcutaneous administration of rituximab. Patient Prefer Adherence. 2016;10:1767-1776doi: 10.2147/PPA.S108489.
Theodore-Oklota, C., Humphrey, L., Wiesner, C., Schnetzler, G., Hudgens, S., & Campbell, A. (2016). Validation of a treatment satisfaction questionnaire in non-Hodgkin lymphoma: assessing the change from intravenous to subcutaneous administration of rituximab. Patient preference and adherence, 101767-1776. https://doi.org/10.2147/PPA.S108489
Theodore-Oklota, Christina, et al. "Validation of a treatment satisfaction questionnaire in non-Hodgkin lymphoma: assessing the change from intravenous to subcutaneous administration of rituximab." Patient preference and adherence vol. 10 (2016): 1767-1776. doi: https://doi.org/10.2147/PPA.S108489
Theodore-Oklota C, Humphrey L, Wiesner C, Schnetzler G, Hudgens S, Campbell A. Validation of a treatment satisfaction questionnaire in non-Hodgkin lymphoma: assessing the change from intravenous to subcutaneous administration of rituximab. Patient Prefer Adherence. 2016 Sep 13;10:1767-1776. doi: 10.2147/PPA.S108489. eCollection 2016. PMID: 27695295; PMCID: PMC5028167.
Copy Download .nbib Format: NLM
Electron induced nanoscale engineering of rutile TiO.

Nanotechnology

Humphrey DS, Pang CL, Chen Q, Thornton G.
PMID: 30411713
Nanotechnology. 2019 Jan 11;30(2):025303. doi: 10.1088/1361-6528/aae95b.

Electron stimulated modifications of the rutile TiO

Cite
Humphrey DS, Pang CL, Chen Q, et al. Electron induced nanoscale engineering of rutile TiO. Nanotechnology. 2019;30(2):025303doi: 10.1088/1361-6528/aae95b.
Humphrey, D. S., Pang, C. L., Chen, Q., & Thornton, G. (2019). Electron induced nanoscale engineering of rutile TiO. Nanotechnology, 30(2), 025303. https://doi.org/10.1088/1361-6528/aae95b
Humphrey, David S, et al. "Electron induced nanoscale engineering of rutile TiO." Nanotechnology vol. 30,2 (2019): 025303. doi: https://doi.org/10.1088/1361-6528/aae95b
Humphrey DS, Pang CL, Chen Q, Thornton G. Electron induced nanoscale engineering of rutile TiO. Nanotechnology. 2019 Jan 11;30(2):025303. doi: 10.1088/1361-6528/aae95b. PMID: 30411713.
Copy Download .nbib Format: NLM
Introduction.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]

Narins RS, Humphrey S.
PMID: 30358627
Dermatol Surg. 2018 Nov;44:S1. doi: 10.1097/DSS.0000000000001687.

No abstract available.

Cite
Narins RS, Humphrey S. Introduction. Dermatol Surg. 2018;44:S1doi: 10.1097/DSS.0000000000001687.
Narins, R. S., & Humphrey, S. (2018). Introduction. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 44S1. https://doi.org/10.1097/DSS.0000000000001687
Narins, Rhoda S, and Humphrey, Shannon. "Introduction." Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] vol. 44 (2018): S1. doi: https://doi.org/10.1097/DSS.0000000000001687
Narins RS, Humphrey S. Introduction. Dermatol Surg. 2018 Nov;44:S1. doi: 10.1097/DSS.0000000000001687. PMID: 30358627.
Copy Download .nbib Format: NLM
Evaluating spatio-temporal soil erosion dynamics in the Winam Gulf catchment, Kenya for enhanced decision making in the land-lake interface.

The Science of the total environment

Humphrey OS, Osano O, Aura CM, Marriott AL, Dowell SM, Blake WH, Watts MJ.
PMID: 34843789
Sci Total Environ. 2021 Nov 26;151975. doi: 10.1016/j.scitotenv.2021.151975. Epub 2021 Nov 26.

Soil erosion accelerated by poor agricultural practices, land degradation, deprived infrastructure development and other anthropogenic activities has important implications for nutrient cycling, land and lake productivity, loss of livelihoods and ecosystem services, as well as socioeconomic disruption. Enhanced knowledge...

Cite
Humphrey OS, Osano O, Aura CM, et al. Evaluating spatio-temporal soil erosion dynamics in the Winam Gulf catchment, Kenya for enhanced decision making in the land-lake interface. Sci Total Environ. 2021;151975doi: 10.1016/j.scitotenv.2021.151975.
Humphrey, O. S., Osano, O., Aura, C. M., Marriott, A. L., Dowell, S. M., Blake, W. H., & Watts, M. J. (2021). Evaluating spatio-temporal soil erosion dynamics in the Winam Gulf catchment, Kenya for enhanced decision making in the land-lake interface. The Science of the total environment, 151975. https://doi.org/10.1016/j.scitotenv.2021.151975
Humphrey, Olivier S, et al. "Evaluating spatio-temporal soil erosion dynamics in the Winam Gulf catchment, Kenya for enhanced decision making in the land-lake interface." The Science of the total environment vol. (2021): 151975. doi: https://doi.org/10.1016/j.scitotenv.2021.151975
Humphrey OS, Osano O, Aura CM, Marriott AL, Dowell SM, Blake WH, Watts MJ. Evaluating spatio-temporal soil erosion dynamics in the Winam Gulf catchment, Kenya for enhanced decision making in the land-lake interface. Sci Total Environ. 2021 Nov 26;151975. doi: 10.1016/j.scitotenv.2021.151975. Epub 2021 Nov 26. PMID: 34843789.
Copy Download .nbib Format: NLM
Finding new and better ways to touch--keeping ahead of healthcare changes.

Home healthcare nurse

Humphrey CJ.
PMID: 9418424
Home Healthc Nurse. 1997 Nov;15(11):753. doi: 10.1097/00004045-199711000-00001.

No abstract available.

Cite
Humphrey CJ. Finding new and better ways to touch--keeping ahead of healthcare changes. Home Healthc Nurse. 1997;15(11):753doi: 10.1097/00004045-199711000-00001.
Humphrey, C. J. (1997). Finding new and better ways to touch--keeping ahead of healthcare changes. Home healthcare nurse, 15(11), 753. https://doi.org/10.1097/00004045-199711000-00001
Humphrey, C J. "Finding new and better ways to touch--keeping ahead of healthcare changes." Home healthcare nurse vol. 15,11 (1997): 753. doi: https://doi.org/10.1097/00004045-199711000-00001
Humphrey CJ. Finding new and better ways to touch--keeping ahead of healthcare changes. Home Healthc Nurse. 1997 Nov;15(11):753. doi: 10.1097/00004045-199711000-00001. PMID: 9418424.
Copy Download .nbib Format: NLM
Fatal Disseminated Mucormycosis in a Hematological Immunocompromised Patient with Extensive Voriconazole Exposure: A Case Report and Review of the Literature.

Case reports in dermatology

Humphrey VS, Li X, Choudhary S, Patton T.
PMID: 33173476
Case Rep Dermatol. 2020 Oct 08;12(3):168-173. doi: 10.1159/000508457. eCollection 2020.

Disseminated mucormycosis is a rare, opportunistic, and aggressive infection typically presenting in immunocompromised patients. Herein, we report a 55-year-old male with a past medical history of Philadelphia-negative B-cell acute lymphoblastic leukemia who presented with a 2-month history of non-painful...

Cite
Humphrey VS, Li X, Choudhary S, et al. Fatal Disseminated Mucormycosis in a Hematological Immunocompromised Patient with Extensive Voriconazole Exposure: A Case Report and Review of the Literature. Case Rep Dermatol. 2020;12(3):168-173doi: 10.1159/000508457.
Humphrey, V. S., Li, X., Choudhary, S., & Patton, T. (2020). Fatal Disseminated Mucormycosis in a Hematological Immunocompromised Patient with Extensive Voriconazole Exposure: A Case Report and Review of the Literature. Case reports in dermatology, 12(3), 168-173. https://doi.org/10.1159/000508457
Humphrey, Victoria S, et al. "Fatal Disseminated Mucormycosis in a Hematological Immunocompromised Patient with Extensive Voriconazole Exposure: A Case Report and Review of the Literature." Case reports in dermatology vol. 12,3 (2020): 168-173. doi: https://doi.org/10.1159/000508457
Humphrey VS, Li X, Choudhary S, Patton T. Fatal Disseminated Mucormycosis in a Hematological Immunocompromised Patient with Extensive Voriconazole Exposure: A Case Report and Review of the Literature. Case Rep Dermatol. 2020 Oct 08;12(3):168-173. doi: 10.1159/000508457. eCollection 2020. PMID: 33173476; PMCID: PMC7588686.
Copy Download .nbib Format: NLM
Study protocol for a cluster randomised controlled feasibility trial evaluating personalised care planning for older people with frailty: PROSPER V2 27/11/18.

Pilot and feasibility studies

Heaven A, Bower P, Cundill B, Farrin A, Foster M, Foy R, Hartley S, Hawkins R, Hulme C, Humphrey S, Lawton R, Parker C, Pendleton N, West R, Young J, Clegg A.
PMID: 32355566
Pilot Feasibility Stud. 2020 Apr 28;6:56. doi: 10.1186/s40814-020-00598-x. eCollection 2020.

BACKGROUND: Frailty is characterised by increased vulnerability to falls, disability, hospitalisation and care home admission. However, it is relatively reversible in the early stages. Older people living with frailty often have multiple health and social issues which are difficult...

Cite
Heaven A, Bower P, Cundill B, et al. Study protocol for a cluster randomised controlled feasibility trial evaluating personalised care planning for older people with frailty: PROSPER V2 27/11/18. Pilot Feasibility Stud. 2020;6:56doi: 10.1186/s40814-020-00598-x.
Heaven, A., Bower, P., Cundill, B., Farrin, A., Foster, M., Foy, R., Hartley, S., Hawkins, R., Hulme, C., Humphrey, S., Lawton, R., Parker, C., Pendleton, N., West, R., Young, J., & Clegg, A. (2020). Study protocol for a cluster randomised controlled feasibility trial evaluating personalised care planning for older people with frailty: PROSPER V2 27/11/18. Pilot and feasibility studies, 656. https://doi.org/10.1186/s40814-020-00598-x
Heaven, Anne, et al. "Study protocol for a cluster randomised controlled feasibility trial evaluating personalised care planning for older people with frailty: PROSPER V2 27/11/18." Pilot and feasibility studies vol. 6 (2020): 56. doi: https://doi.org/10.1186/s40814-020-00598-x
Heaven A, Bower P, Cundill B, Farrin A, Foster M, Foy R, Hartley S, Hawkins R, Hulme C, Humphrey S, Lawton R, Parker C, Pendleton N, West R, Young J, Clegg A. Study protocol for a cluster randomised controlled feasibility trial evaluating personalised care planning for older people with frailty: PROSPER V2 27/11/18. Pilot Feasibility Stud. 2020 Apr 28;6:56. doi: 10.1186/s40814-020-00598-x. eCollection 2020. PMID: 32355566; PMCID: PMC7187486.
Copy Download .nbib Format: NLM
Structure of a model TiO.

Nature materials

Hussain H, Tocci G, Woolcot T, Torrelles X, Pang CL, Humphrey DS, Yim CM, Grinter DC, Cabailh G, Bikondoa O, Lindsay R, Zegenhagen J, Michaelides A, Thornton G.
PMID: 27842073
Nat Mater. 2017 Apr;16(4):461-466. doi: 10.1038/nmat4793. Epub 2016 Nov 14.

The interaction of water with TiO

Cite
Hussain H, Tocci G, Woolcot T, et al. Structure of a model TiO. Nat Mater. 2016;16(4):461-466doi: 10.1038/nmat4793.
Hussain, H., Tocci, G., Woolcot, T., Torrelles, X., Pang, C. L., Humphrey, D. S., Yim, C. M., Grinter, D. C., Cabailh, G., Bikondoa, O., Lindsay, R., Zegenhagen, J., Michaelides, A., & Thornton, G. (2017). Structure of a model TiO. Nature materials, 16(4), 461-466. https://doi.org/10.1038/nmat4793
Hussain, H, et al. "Structure of a model TiO." Nature materials vol. 16,4 (2017): 461-466. doi: https://doi.org/10.1038/nmat4793
Hussain H, Tocci G, Woolcot T, Torrelles X, Pang CL, Humphrey DS, Yim CM, Grinter DC, Cabailh G, Bikondoa O, Lindsay R, Zegenhagen J, Michaelides A, Thornton G. Structure of a model TiO. Nat Mater. 2017 Apr;16(4):461-466. doi: 10.1038/nmat4793. Epub 2016 Nov 14. PMID: 27842073.
Copy Download .nbib Format: NLM
Soluble guanylate cyclase signalling mediates etoposide resistance in progressing small cell lung cancer.

Nature communications

Schenk MW, Humphrey S, Hossain ASMM, Revill M, Pearsall S, Lallo A, Brown S, Bratt S, Galvin M, Descamps T, Zhou C, Pearce SP, Priest L, Greenhalgh M, Chaturvedi A, Kerr A, Blackhall F, Dive C, Frese KK.
PMID: 34789728
Nat Commun. 2021 Nov 17;12(1):6652. doi: 10.1038/s41467-021-26823-6.

Small cell lung cancer (SCLC) has a 5-year survival rate of

Cite
Schenk MW, Humphrey S, Hossain ASMM, et al. Soluble guanylate cyclase signalling mediates etoposide resistance in progressing small cell lung cancer. Nat Commun. 2021;12(1):6652doi: 10.1038/s41467-021-26823-6.
Schenk, M. W., Humphrey, S., Hossain, A. S. M. M., Revill, M., Pearsall, S., Lallo, A., Brown, S., Bratt, S., Galvin, M., Descamps, T., Zhou, C., Pearce, S. P., Priest, L., Greenhalgh, M., Chaturvedi, A., Kerr, A., Blackhall, F., Dive, C., & Frese, K. K. (2021). Soluble guanylate cyclase signalling mediates etoposide resistance in progressing small cell lung cancer. Nature communications, 12(1), 6652. https://doi.org/10.1038/s41467-021-26823-6
Schenk, Maximilian W, et al. "Soluble guanylate cyclase signalling mediates etoposide resistance in progressing small cell lung cancer." Nature communications vol. 12,1 (2021): 6652. doi: https://doi.org/10.1038/s41467-021-26823-6
Schenk MW, Humphrey S, Hossain ASMM, Revill M, Pearsall S, Lallo A, Brown S, Bratt S, Galvin M, Descamps T, Zhou C, Pearce SP, Priest L, Greenhalgh M, Chaturvedi A, Kerr A, Blackhall F, Dive C, Frese KK. Soluble guanylate cyclase signalling mediates etoposide resistance in progressing small cell lung cancer. Nat Commun. 2021 Nov 17;12(1):6652. doi: 10.1038/s41467-021-26823-6. PMID: 34789728; PMCID: PMC8599617.
Copy Download .nbib Format: NLM
Screening for diabetes.

The New Zealand medical journal

Humphrey AR.
PMID: 12206156
N Z Med J. 2002 Jun 21;115(1156):304; author reply 304.

No abstract available.

Cite
Humphrey AR. Screening for diabetes. N Z Med J. 2002;115(1156):304; author reply 304
Humphrey, A. R. (2002). Screening for diabetes. The New Zealand medical journal, 115(1156), 304; author reply 304.
Humphrey, Alistar R. "Screening for diabetes." The New Zealand medical journal vol. 115,1156 (2002): 304; author reply 304.
Humphrey AR. Screening for diabetes. N Z Med J. 2002 Jun 21;115(1156):304; author reply 304. PMID: 12206156.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 141 entries